<code id='F7DF1F2AB0'></code><style id='F7DF1F2AB0'></style>
    • <acronym id='F7DF1F2AB0'></acronym>
      <center id='F7DF1F2AB0'><center id='F7DF1F2AB0'><tfoot id='F7DF1F2AB0'></tfoot></center><abbr id='F7DF1F2AB0'><dir id='F7DF1F2AB0'><tfoot id='F7DF1F2AB0'></tfoot><noframes id='F7DF1F2AB0'>

    • <optgroup id='F7DF1F2AB0'><strike id='F7DF1F2AB0'><sup id='F7DF1F2AB0'></sup></strike><code id='F7DF1F2AB0'></code></optgroup>
        1. <b id='F7DF1F2AB0'><label id='F7DF1F2AB0'><select id='F7DF1F2AB0'><dt id='F7DF1F2AB0'><span id='F7DF1F2AB0'></span></dt></select></label></b><u id='F7DF1F2AB0'></u>
          <i id='F7DF1F2AB0'><strike id='F7DF1F2AB0'><tt id='F7DF1F2AB0'><pre id='F7DF1F2AB0'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:3441
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          An outdated Medicare rule harms dementia patients with anxiety
          An outdated Medicare rule harms dementia patients with anxiety

          CarstenKoall/GettyImagesMemorylossisthemostobvioussymptomofAlzheimer’sdisease.Butforthemorethan6.5mi

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Fight over Supreme Court dialysis ruling puts kidney patients at risk

          AdobeAssoonassheheardtheSupremeCourtdecision,LaVarneBurtonbegantoworry.AsCEOofthenonprofitAmericanKi